🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Aňa Lluch

Universitat de València

ORCID: 0000-0003-2766-407X

Also affiliated with Instituto de Salud Carlos III, Hospital Clínico Universitario de Valencia, INCLIVA Health Research Institute

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile
0Author DataRank

Indexed papers

3in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 3 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Supplemental Figure 3 from Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Figshare(2023)10.1158/0008-5472.22378737.v1
Top 100%
0DataRank
Top 100%0 citations

Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee +22 more

Papers

Driven by 6 papers — median percentile 0. Top paper: “Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer”.

Selective AKT kinase inhibitor capivasertib in combination with fulvestrant in PTEN-mutant ER-positive metastatic breast cancer

npj Breast Cancer(2021)10.1038/s41523-021-00251-7
N/A
1.4DataRank · unranked
36 citations

Gerald Batist, Funda Meric‐Bernstam, Peter Kabos, Iben Spanggaard, Aňa Lluch +22 more

Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

UNC Libraries(2020)10.17615/twk7-x350
N/A
0DataRank · unranked
0 citations

Victor Weigman, Nicholas J. Wang, Vicente Valero, Aňa Lluch, Jane Fridlyand +22 more

Distinct GSDMB protein isoforms and protease cleavage processes differentially control pyroptotic cell death and mitochondrial damage in cancer cells

Cell Death and Differentiation(2023)10.1038/s41418-023-01143-y
N/A
0DataRank · unranked
81 citations

Sara Colomo, Laura Sin, María Pérez-López, Sara Lázaro, Ángela Molina-Crespo +16 more

Supplemental Figure 3 from Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

Figshare(2023)10.1158/0008-5472.22378737.v1
Top 100%
0DataRank
Top 100%0 citations

Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee +22 more

Data from An Integrative Genomic and Proteomic Analysis of PIK3CA, PTEN, and AKT Mutations in Breast Cancer

(2023)10.1158/0008-5472.c.6497325
Top 100%
0DataRank
Top 100%0 citations

Ana M. González-Angulo, Aňa Lluch, Richard M. Neve, Wen-lin Kuo, Michael A. Davies +17 more

Supplementary Table 4 from Characterization of a Naturally Occurring Breast Cancer Subset Enriched in Epithelial-to-Mesenchymal Transition and Stem Cell Characteristics

(2023)10.1158/0008-5472.22378674
Top 100%
0DataRank
Top 100%0 citations

Ana-Maria Gonzalez-Angulo, Katherine Stemke‐Hale, Michael Z. Gilcrease, Savitri Krishnamurthy, Ju‐Seog Lee +22 more